Mobile Tablet Education to Advance Caregiver Health (MTEACHing)
24. april 2019 oppdatert av: VA Office of Research and Development
Mobile Media Intervention for Family Caregivers of Veterans With Dementia
To address the high burden of caring for a Veteran with dementia, the investigators propose to study the effect of a low-cost, rehabilitative intervention for family caregivers of Veterans with dementia.
The investigators' novel approach will use mobile media technology that can reach caregivers in rural areas who do not have easy access to major VA medical centers.
If this rehabilitative intervention proves successful, it may represent an approach to Veteran and family-centered dementia care that can be used throughout VA with low staff, resource, and cost burdens.
Studieoversikt
Status
Fullført
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The proposed project studies the effects of an education and skill-building rehabilitation intervention, designed to be low-cost and clinically translatable through mobile media devices (i.e., tablets), on family caregivers of Veterans with dementia. Intervention effects will be examined longitudinally at baseline and 3 months post-intervention.
Advanced statistical techniques will be used to determine the impact of the intervention on: quality of life in caregivers of Veterans with dementia (Aim 1), perceived stress and depressive symptoms in caregivers (Aim 2), and socialization and engagement in pleasant activities in caregivers (Aim 3).
If this rehabilitative intervention proves successful, it may represent an approach to Veteran- and family-centered dementia care that can be used throughout VA with low staff, resource, and cost burdens.
Studietype
Intervensjonell
Registrering (Faktiske)
16
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
California
-
Palo Alto, California, Forente stater, 94304-1290
- VA Palo Alto Health Care System, Palo Alto, CA
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
18 år og eldre (Voksen, Eldre voksen)
Tar imot friske frivillige
Ja
Kjønn som er kvalifisert for studier
Alle
Beskrivelse
Inclusion Criteria:
-- Participants must:
- report distress associated with being the primary caregiver for a family member with dementia
- reporting at least 2 of the following 6 items at baseline assessment: felt overwhelmed, felt like they often needed to cry, were angry or frustrated, felt they were cut off from family or friends, reported moderate to high levels of general stress, or felt their health had declined
- provide at least 7 hours of care (supervision or direct assistance) per week over the past 3 months (other sources of caregiving for the Veteran with dementia can also be utilized; e.g., respite, home health aide, other family members)
- cohabitate with a Veteran diagnosed with dementia
- be proficient in spoken and written English
- be capable of providing informed consent
Exclusion Criteria:
-- Potential participants will be screened and excluded for:
- current or lifetime history of any psychiatric disorder with psychotic features
- prominent suicidal or homicidal ideation
- having met DSM-IV criteria for drug or alcohol abuse or dependence (except nicotine) within the past six months
- presence of alcohol intoxication (by breathalyzer) or alcohol withdrawal (by exam) during study recruitment or participation
- diagnosis of probable or possible dementia
- a Telephone Cognitive Screen score of < 20
- participation in another caregiver intervention study within the past year
- lack of access to telephone and internet services in the home
- illness that would prevent study participation
- planned transfer of care receiver to another caregiver or nursing home within 6 months
- currently living with an implantable cardioverter defibrillator or pacemaker
- known pregnancy at time of consent
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Ingen (Open Label)
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: Mobile Media Education and Skill-Building Rehabilitation Int
The investigators' ESBR-m intervention consists of four, 90-minute group (= 5 participants) sessions.
These four sessions are supplemented with a booster session one month following the last intervention session.
|
Participants randomized to the ESBR-m group will participate in four, 90-minute group ( 5 participants) sessions.
These four sessions are supplemented with a booster session one month following the last intervention session.
|
|
Aktiv komparator: Usual Care
Usual Care (plus supplemental educational materials).
Participants randomized to the Usual Care (UC) group will receive supplemental educational materials (e.g., VA Caregiver Support Program; Veterans Crisis Line; National Institute on Aging's "Understanding Memory Loss").
|
Participants randomized to the UC group will receive supplemental educational materials (e.g., VA Caregiver Support Program; Veterans Crisis Line; National Institute on Aging's "Understanding Memory Loss").
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Change From Baseline Zarit Burden Interview (ZBI) at 4 Months
Tidsramme: Baseline, 4 month follow-up
|
The Zarit Burden Interview (ZBI) is a 22-item self-report measure of caregiver burden.
Several version of the ZBI have been used successfully as outcome measures in interventions for dementia caregivers.
Scores for each item range from 0 (never) to 4 (nearly always) on questions such as "Do you feel embarrassed by your relative's behavior?."
Total scores are calculated by summing all responses and range from 0-88.
A higher score is indicative of a worse outcome.
|
Baseline, 4 month follow-up
|
|
Change From Baseline Center for Epidemiological Studies-Depression (CES-D) at 4 Months
Tidsramme: Baseline, 4 month follow-up
|
The Center for Epidemiological Studies-Depression (CES-D) is a 20-item, self-report measure of frequency of depressive symptoms over a one week period.
The CES-D is frequently used to assess depression in dementia caregivers and has been shown to be sensitive to changes in caregiver depression post intervention.
Scores for each item range from 0 (rarely or none of the time) to 3 (most or all of the time), with some items reverse coded.
Total scores are calculated by summing all responses and range from 0-60.
A higher score is indicative of a worse outcome.
|
Baseline, 4 month follow-up
|
|
Change From Baseline Perceived Stress Scale (PSS) at 4 Months
Tidsramme: Baseline, 4 month follow-up
|
The Perceived Stress Scale (PSS) is the most widely used psychological instrument for measuring the perception of stress.
It is a measure of the degree to which situations in one's life are appraised as stressful.
Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.
The scale also includes a number of direct queries about current levels of experienced stress.
We use a 14 item version of the PSS with a minimum score of 0 and a maximum score of 56.
Lower values indicate lower perceived stress while higher values indicate higher perceived stress.
|
Baseline, 4 month follow-up
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Etterforskere
- Hovedetterforsker: Blake K Scanlon, PhD, VA Palo Alto Health Care System, Palo Alto, CA
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
1. januar 2015
Primær fullføring (Faktiske)
31. desember 2017
Studiet fullført (Faktiske)
30. juni 2018
Datoer for studieregistrering
Først innsendt
23. januar 2018
Først innsendt som oppfylte QC-kriteriene
30. januar 2018
Først lagt ut (Faktiske)
31. januar 2018
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
15. juli 2019
Siste oppdatering sendt inn som oppfylte QC-kriteriene
24. april 2019
Sist bekreftet
1. januar 2019
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- E1710-P
- 1I21RX001710 (U.S. NIH-stipend/kontrakt)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
UBESLUTTE
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
produkt produsert i og eksportert fra USA
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .